Moreover, palbociclib induced AMPK activation and autophagy in both control and CDK4/6 knockdown Hep3B cells, suggesting that palbociclib elicits its anti‐HCC activity independently of the CDK4/6‐Rb pathway (Fig. 4C). The gene discussed is RB1; the disease is hepatocellular carcinoma.